Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Active Not Recruiting NCT04794101

Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Conditions: X-Linked Retinitis Pigmentosa

Sex: All

Ages: 3 Years – N/A

Healthy volunteers: No

Phase: PHASE3

Enrollment: 97

Sponsor: Janssen Research & Development, LLC

Location: Shiley Eye Institute Jacobs Retina Center La Jolla California

Summary

A clinical trial of AAV5-hRKp.RPGR vector for participants with X-linked retinitis pigmentosa (XLRP)

Eligibility Criteria

Inclusion Criteria: * Male or female, 3 years of age or older, has XLRP confirmed by a retinal specialist and has a predicted disease-causing sequence variant in RPGR confirmed by an accredited laboratory. Exclusion Criteria: * None

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04794101). StuddyBuddy aggregates publicly available trial information.